Mkts

Aquestive Therapeutics, Inc.

NASDAQ: AQST
$3.57-0.01 (-0.28%)
As of Nov 12, 4:00 PM ET

Key statistics

Day range
3.453.68
52-week range
2.936.74
Today
Open3.56
Previous close3.57
Volume—
Valuation
Market cap445.56M
P/E ratio—
EPS (TTM)-0.64
Income & risk
Dividend / yield—
Beta1.66
Avg volume2.59M
Discussion

AQST News

Stories mentioning AQST from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue14,44613,01512,80710,0038,72011,86713,54220,099
Cost of Goods Sold3,4695,8364,5064,5613,6524,5204,4374,526
Gross Profit10,9777,1798,3015,4425,0687,3479,10515,573
Operating Expenses
Research & Development4,2043,1964,5304,1055,3614,9175,2694,162
Sales General & Admin10,97732,82215,25012,70519,07216,00912,12611,356
Total Operating Expenses
Operating Income (Loss)(4,204)(28,839)(11,479)(11,368)(19,365)(13,579)(8,290)55.00
Interest Income
Interest Expense2,779
Other Expense
Pretax Income(8,057)(31,860)(15,446)(13,548)(22,930)(17,069)(11,509)(2,745)
Tax Provision0.000.000.000.000.00(14.00)0.000.00
Net Income (Loss)(8,057)(31,860)(15,446)(13,548)(22,930)(17,055)(11,509)(2,745)
Earnings Per Share (Basic)(0.07)(0.30)(0.14)(0.14)(0.24)(0.20)(0.13)(0.03)
Earnings Per Share (Diluted)(0.07)(0.30)(0.14)(0.14)(0.24)(0.20)(0.13)(0.03)
Weighted Average Shares Outstanding (Basic)122,610106,927110,58499,32795,49786,72691,08290,912
Weighted Average Shares Outstanding (Diluted)122,610106,927110,58499,32795,49786,72691,08290,912

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About AQST

Aquestive Therapeutics, Inc. (NASDAQ: AQST) is a stock listed on the Nasdaq Stock Market under the ticker symbol AQST. It last traded at $3.57 (Nov 12, 2026, 4:00 PM ET), down 0.3% on the day. That gives Aquestive Therapeutics a market capitalisation of $445.6M.

Over the past 52 weeks AQST has traded between $2.93 and $6.74.

Revenue for the quarter ended Mar 31, 2026 was $14.4M; a net loss of $8.1M. Revenue was up 65.7% from $8.7M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$14.4M-$8.1M-55.8%
Dec 31, 2025$13.0M-$31.9M-244.8%
Sep 30, 2025$12.8M-$15.4M-120.6%
Jun 30, 2025$10.0M-$13.5M-135.4%

From Aquestive Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…